Ocugen (OCGN) Other Non-Current Assets (2014 - 2026)

Ocugen (OCGN) reported Other Non-Current Assets of $4.2 million for Q1 2026, up 1261.17% on a YoY basis from $309000.0 in Q1 2025, and up 1231.01% quarter-over-quarter from $316000.0 in Q4 2025.

Ocugen (OCGN) Other Non-Current Assets (2014 - 2026) Analysis & Trends

Ocugen has reported Other Non-Current Assets for 13 years, with the latest figure at $4.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 1261.17% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (up 1261.17% YoY), and the FY2025 full-year result was $316000.0, up 2.93% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $4.2 million, up from $316000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $5.0 million in Q2 2025, with the low at $302000.0 in Q2 2024.
  • Historically, Other Non-Current Assets has averaged $2.3 million across 5 years, with a median of $1.6 million in 2022.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 2791.39% — and 2025, when it rose 2.93%.
  • Ocugen's Other Non-Current Assets stood at $4.1 million in 2022, then fell by 3.45% to $3.9 million in 2023, then plunged by 92.22% to $307000.0 in 2024, then gained by 2.93% to $316000.0 in 2025, then jumped by 1231.01% to $4.2 million in 2026.
  • The last three Other Non-Current Assets figures came in at $4.2 million (Q1 2026), $316000.0 (Q4 2025), and $314000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ocugen 411.07 Mn 411.07 Mn - 4.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.21 Mn
Dec 31, 2025 316,000.00
Sep 30, 2025 314,000.00
Jun 30, 2025 4.95 Mn
Mar 31, 2025 309,000.00
Dec 31, 2024 307,000.00
Sep 30, 2024 305,000.00
Jun 30, 2024 302,000.00
Mar 31, 2023 3.95 Mn
Dec 31, 2022 4.09 Mn
Sep 30, 2022 4.23 Mn
Jun 30, 2022 4.37 Mn
Mar 31, 2022 1.63 Mn
Dec 31, 2021 151,000.00
Sep 30, 2021 151,000.00
Jun 30, 2021 151,000.00
Mar 31, 2021 151,000.00
Dec 31, 2020 714,000.00
Sep 30, 2020 151,000.00
Jun 30, 2020 151,000.00